Diabetic Medicine Meneghini, L, Doshi, A, Gouet, D, Vilsbøll, T, Begtrup, K, Őrsy, P, Ranthe, M F & Lingvay, I 2020, ' Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin ', Diabetic Medicine, vol. 37, no. 2, pp. 267-276 . https://doi.org/10.1111/dme.14178